As I predicted, Lancet paper on HCQ retracted by three of the authors. The fourth author had no comment. He's the owner of the fake company that supplied the data for the paper.
Another paper published by the New England Journal of Medicine: They looked at the ability of HCQ as a post exposure prophylactic. Summary: If you wait four days after the exposure, HCQ does not seem to do much good. There were a few problems. For example, not many of the participants were confirmed to actually have Covid-19 with PCR tests. They also kind of missed the point because zinc was not part of their design, though some of the participants were taking zinc in both control and HCQ arms. Taking zinc was strictly self-reported, so uncontrolled. They also ended up with some very small numbers, so not much of significance could be reported.
They included hospitalizations and death as secondary end points, but halted the study when their primary end point failed. Since the whole idea of an antiviral is to prevent serious illness and hospitalization, it would have been nice if they reported those numbers. So we still don't have confirmation that early HCQ + zinc cuts mortality in half as reported elsewhere.
